Variant report

Variant	esv1835200
Chromosome Location	chr3:47642233-47654375
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr3:47650178-47650187	K562	blood:	n/a	n/a
2	CEBPB	chr3:47653645-47654038	IMR90	lung:	n/a	n/a
3	CEBPB	chr3:47653796-47653995	K562	blood:	n/a	n/a
4	CEBPB	chr3:47646751-47646845	K562	blood:	n/a	chr3:47646789-47646800
5	CEBPB	chr3:47646665-47646916	HepG2	liver:	n/a	chr3:47646789-47646800
6	CEBPB	chr3:47646691-47646968	IMR90	lung:	n/a	chr3:47646789-47646800
7	CTCF	chr3:47647125-47647191	GM20000	blood:	n/a	n/a
8	CUX1	chr3:47653814-47653923	K562	blood:	n/a	n/a
9	E2F4	chr3:47653352-47653452	MCF10A-Er-Src	breast:	n/a	n/a
10	EP300	chr3:47648633-47648672	GM12878	blood:	n/a	n/a
11	FOS	chr3:47647182-47647588	HUVEC	blood vessel:	n/a	chr3:47647395-47647406
12	GATA2	chr3:47653618-47654080	HUVEC	blood vessel:	n/a	chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653826-47653836 chr3:47653825-47653837 chr3:47653827-47653836
13	GATA3	chr3:47653551-47654115	SK-N-SH	brain:	n/a	chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653826-47653836 chr3:47653825-47653837 chr3:47653827-47653836
14	GATA3	chr3:47653477-47653975	T-47D	breast:	n/a	chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653826-47653836 chr3:47653825-47653837 chr3:47653827-47653836
15	GATA3	chr3:47653500-47654209	SK-N-SH	brain:	n/a	chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653823-47653839 chr3:47653827-47653834 chr3:47653826-47653836 chr3:47653825-47653837 chr3:47653827-47653836
16	JUN	chr3:47653698-47653796	K562	blood:	n/a	n/a
17	JUND	chr3:47642471-47642500	H1-hESC	embryonic stem cell:	n/a	n/a
18	JUND	chr3:47653737-47654036	K562	blood:	n/a	n/a
19	MAX	chr3:47644948-47645098	NB4	blood:	n/a	chr3:47645028-47645038 chr3:47645086-47645096
20	NFIC	chr3:47653502-47654146	SK-N-SH	brain:	n/a	chr3:47653865-47653881
21	NFIC	chr3:47653604-47654140	ECC-1	luminal epithelium:	n/a	chr3:47653865-47653881
22	NFIC	chr3:47653543-47654077	ECC-1	luminal epithelium:	n/a	chr3:47653865-47653881
23	POLR2A	chr3:47647196-47647428	U87	brain:	n/a	n/a
24	POLR2A	chr3:47647157-47647428	U87	brain:	n/a	n/a
25	POLR2A	chr3:47653431-47653474	HepG2	liver:	n/a	n/a
26	POLR2A	chr3:47645964-47646332	K562	blood:	n/a	n/a
27	POLR2A	chr3:47647022-47647209	MCF-7	breast:	n/a	n/a
28	POLR2A	chr3:47645898-47645923	HepG2	liver:	n/a	n/a
29	POLR2A	chr3:47642837-47643136	K562	blood:	n/a	n/a
30	POLR2A	chr3:47646841-47646932	K562	blood:	n/a	n/a
31	POLR2A	chr3:47653333-47653384	HepG2	liver:	n/a	n/a
32	POLR2A	chr3:47651587-47651980	K562	blood:	n/a	n/a
33	POLR2A	chr3:47644053-47644494	SK-N-MC	brain:	n/a	n/a
34	POLR2A	chr3:47645060-47645079	HUVEC	blood vessel:	n/a	n/a
35	POLR2A	chr3:47651330-47651674	HepG2	liver:	n/a	n/a
36	POLR2A	chr3:47651954-47651992	HUVEC	blood vessel:	n/a	n/a
37	POLR2A	chr3:47650170-47650317	Hela-S3	cervix:	n/a	n/a
38	POLR2A	chr3:47651874-47652001	K562	blood:	n/a	n/a
39	POLR2A	chr3:47644943-47645065	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr3:47651533-47651711	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr3:47653842-47653845	K562	blood:	n/a	n/a
42	POLR2A	chr3:47652061-47652072	HUVEC	blood vessel:	n/a	n/a
43	POLR2A	chr3:47646908-47647237	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr3:47649721-47649868	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr3:47642901-47642989	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr3:47649619-47650216	HepG2	liver:	n/a	n/a
47	POLR2A	chr3:47645928-47645997	HepG2	liver:	n/a	n/a
48	POLR2A	chr3:47653669-47654023	U87	brain:	n/a	n/a
49	POLR2A	chr3:47651413-47651864	K562	blood:	n/a	n/a
50	POLR2A	chr3:47643665-47643877	MCF-7	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:47644023..47648902-chr3:47649054..47653658,7	K562	blood:
2	chr3:47649126..47651542-chr3:47653050..47654614,2	K562	blood:
3	chr3:47652301..47655679-chr3:47656757..47659038,4	K562	blood:
4	chr3:47603181..47605657-chr3:47642567..47645013,2	K562	blood:
5	chr3:47652393..47654345-chr3:47713182..47715815,2	K562	blood:
6	chr3:47644023..47648902-chr3:47649054..47653658,7	K562	blood:
7	chr3:47649126..47651542-chr3:47653050..47654614,2	K562	blood:
8	chr3:47463893..47464446-chr3:47647653..47648306,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC112512.1-1	chr3:47644835-47646167	ENSG00000214773.1
2	lnc-AC112512.1-1	chr3:47643205-47643299	ENSG00000214773.1

Variant related genes	Relation type
ENSG00000214773	TF binding region
SMARCC1	TF binding region
ENSG00000214773	chromatin interactions
ENSG00000173473	chromatin interactions
ENSG00000114650	chromatin interactions

Extended variants
information (count: 394 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:394 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11130141	chr3:47642233-47642234	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs61620099	chr3:47642245-47642246	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs145129929	chr3:47642294-47642295	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs566374558	chr3:47642335-47642336	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs534491366	chr3:47642387-47642388	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs549378065	chr3:47642409-47642410	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs543546684	chr3:47642436-47642437	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs9860934	chr3:47642474-47642475	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs199643691	chr3:47642489-47642490	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs555458992	chr3:47642490-47642491	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs66582985	chr3:47642521-47642522	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs543015646	chr3:47642541-47642542	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs561304912	chr3:47642559-47642560	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs573451598	chr3:47642620-47642621	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs527274418	chr3:47642621-47642622	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs563093467	chr3:47642625-47642626	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs182929497	chr3:47642693-47642694	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs538397733	chr3:47642710-47642711	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs556807980	chr3:47642716-47642717	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs2049300	chr3:47642726-47642727	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs539184591	chr3:47642734-47642735	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs559733606	chr3:47642805-47642806	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs147570233	chr3:47642860-47642861	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs572380422	chr3:47642878-47642879	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs140278987	chr3:47642893-47642894	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs369347631	chr3:47642928-47642929	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs573881315	chr3:47642949-47642950	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs543962323	chr3:47642979-47642980	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs562382556	chr3:47643027-47643028	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs532859024	chr3:47643077-47643078	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs549733619	chr3:47643078-47643079	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs544739253	chr3:47643101-47643102	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs115329200	chr3:47643106-47643107	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs186197160	chr3:47643119-47643120	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs144530405	chr3:47643168-47643169	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs567824823	chr3:47643185-47643186	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs9861783	chr3:47643188-47643189	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs532086518	chr3:47643192-47643193	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs190180400	chr3:47643226-47643227	Weak transcription Strong transcription Enhancers Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
40	rs11929303	chr3:47643403-47643404	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs539117261	chr3:47643442-47643443	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs553939552	chr3:47643443-47643444	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs566184680	chr3:47643469-47643470	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs6805353	chr3:47643470-47643471	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs370641634	chr3:47643481-47643482	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs375282397	chr3:47643485-47643486	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs368931035	chr3:47643490-47643491	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs569570967	chr3:47643588-47643589	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs182815535	chr3:47643616-47643617	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs528055723	chr3:47643714-47643715	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:546 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:47621000-47651600	Weak transcription	Right Atrium	heart
2	chr3:47621000-47653400	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr3:47622600-47653400	Weak transcription	Stomach Mucosa	stomach
4	chr3:47623400-47655000	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr3:47624000-47653200	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr3:47625400-47651400	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr3:47625600-47651200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
8	chr3:47626200-47698600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr3:47626400-47642600	Strong transcription	Fetal Adrenal Gland	Adrenal Gland
10	chr3:47626400-47655600	Strong transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr3:47626400-47680600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr3:47626600-47688600	Strong transcription	Primary hematopoietic stem cells short term culture	blood
13	chr3:47626600-47699800	Strong transcription	HUES64 Cell Line	embryonic stem cell
14	chr3:47626800-47680800	Strong transcription	Primary T cells fromperipheralblood	blood
15	chr3:47631000-47650000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
16	chr3:47631200-47642600	Weak transcription	Brain Angular Gyrus	brain
17	chr3:47631200-47650200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
18	chr3:47631400-47644200	Weak transcription	Psoas Muscle	Psoas
19	chr3:47632000-47648800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
20	chr3:47632200-47645400	Weak transcription	Skeletal Muscle Male	skeletal muscle
21	chr3:47632200-47647200	Weak transcription	HUVEC	blood vessel
22	chr3:47632200-47648400	Weak transcription	NHDF-Ad	bronchial
23	chr3:47632200-47649200	Weak transcription	Placenta Amnion	Placenta Amnion
24	chr3:47632200-47649800	Weak transcription	Colonic Mucosa	Colon
25	chr3:47632200-47651200	Weak transcription	Right Ventricle	heart
26	chr3:47632400-47646800	Weak transcription	Ovary	ovary
27	chr3:47632400-47651400	Weak transcription	Gastric	stomach
28	chr3:47632400-47651400	Weak transcription	Pancreas	Pancrea
29	chr3:47632400-47652800	Weak transcription	Aorta	Aorta
30	chr3:47632400-47658600	Weak transcription	A549	lung
31	chr3:47632400-47660800	Weak transcription	Esophagus	oesophagus
32	chr3:47632600-47643400	Weak transcription	Primary neutrophils fromperipheralblood	blood
33	chr3:47632600-47648400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
34	chr3:47632800-47644200	Weak transcription	Fetal Kidney	kidney
35	chr3:47632800-47649800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
36	chr3:47632800-47650000	Weak transcription	NHLF	lung
37	chr3:47633200-47645400	Weak transcription	Sigmoid Colon	Sigmoid Colon
38	chr3:47633200-47645800	Weak transcription	Fetal Heart	heart
39	chr3:47633800-47643200	Strong transcription	GM12878-XiMat	blood
40	chr3:47634200-47661000	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
41	chr3:47634400-47645200	Strong transcription	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr3:47634600-47645200	Strong transcription	Fetal Stomach	stomach
43	chr3:47635000-47651400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr3:47635000-47686800	Strong transcription	Dnd41	blood
45	chr3:47636000-47649200	Weak transcription	HMEC	breast
46	chr3:47636400-47647800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr3:47636600-47642600	Weak transcription	Fetal Brain Male	brain
48	chr3:47636600-47642800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
49	chr3:47636600-47645000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr3:47636600-47645000	Weak transcription	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links